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Abstract 
Background: Cyclophosphamide (CPH) is a widely used chemotherapeutic drug that 
can affect the hippocampal neurocytes with a subsequent effect on memory and 
cognitive functions. Nanomedicine has the potential to overcome the current 
chemotherapeutic side effects, because of the unique nanoscale size and distinctive 
bioeffects of nanomaterials. So, the present study aims to investigate the potential 
ameliorative effect of the biologically synthesized nano-selenium (nano Se) on CPH 
induced hippocampal neurotoxicity. 
Materials and methods: Twenty four rats were randomly classified into four groups 
of 6 rats each: control group, nano Se group (dose of 0.5 mg biological nano Se /kg 
daily via oral gavage), CPH group (dose of 20 mg CPH/kg daily intraperitoneally), 
and CPH plus Nano Se group.  After 4 weeks, the rats were sacrificed and the 
hippocampus was excised and processed. Sections were stained with H&E stain and 
immunohistochemically stained for caspase 3 (apoptosis marker) and GFAB 
(astrocytic activity marker). Morphometric analysis and transmission electron 
microscopic (TEM) examination were also done. 
Results: Control and nano Se groups revealed no structural changes. By light 
microscopy, CPH group showed degeneration and necrosis of hippocampal 
neurocytes, significantly reduced thickness of the neurocyte cell layers, increased 
expression of GFAB and caspase 3 immunostains and significantly elevated apoptotic 
index. Moreover, neurocytes damage, mitochondrial cristeolysis, mild dilation of 
rough endoplasmic reticulum (Er), and disrupted neurolemmal sheaths of nerve fibers 
were also demonstrated by TEM. Nano Se cotreatment in the fourth group reversed all 
the aforementioned deleterious changes that induced by CPH in the hippocampal 
neurocytes. 
Conclusions: Treatment with CPH caused damage to hippocampal neurocytes that 
can be reversed by biological nano Se co-treatment. 




Selenium (Se) is an indispensable trace element, needed for the maintenance of 
growth and health [47]. It plays a rule in illness prevention and fertility [9,10]. 
Recently, with the progress of the nanotechnology field, nano selenium ( nano Se ) 
has gained widespread attention because the nanoparticles exhibit innovative 
properties such as a powerful adsorbing capacity, high surface activity, high catalytic 
ability, and less toxicity [46] Some studies have also pointed out the possibility of use 
of nano Se in the field of medical treatment as antimicrobial, anti-biofilm [45] and 
anticancer [57].              
Nano Se can be synthesized by chemical and biological methods. In chemical 
methods, the chemical stabilizers used may lead to environmental pollution [15]. On 
the contrary, biological synthesis is preferred as it is a nontoxic, clean, cost-effective, 
and more accessible approach. Moreover, nanoparticles produced by the biological 
methods have more novel properties [36,19]. There are relatively few reports on the 
biologically synthesized nano Se and it is still a big challenge for researchers to 
elucidate the potential health benefits of nano Se [24]. 
Cyclophosphamide (CPH) is an anticancer agent, which is ordinarily used to treat 
numerous types of cancer [37].  Administration of CPH triggers oxidative stress in the 
brain [25] and massive cellular degeneration [39], consequently provoking apoptosis 
[32], and damage to cancer and healthy cells [49]. CPH uptake into healthy cells is 
higher than in cancer cells, rendering healthy cells more susceptible to damage [8]. 
The antineoplastic effects of CPH are associated with the production of acrolein 
which is the cause of the toxic side effects of CPH [28]. Acrolein diminishes cellular 
defense against oxidative stress, which can corrupt the blood-brain barrier [3,50]. 
Moreover, CPH can alkylate DNA, inhibits the duplication of the genome in dividing 
cells, and arrests the cell cycle particularly at the S-phase [6,51].  
Treatment with CPH induces cognitive and psychological impairments especially 
the hippocampal-dependent memory task due to the negative impact of CPH on 
hippocampal neurogenesis [23,43]. Neurogenesis continues in the hippocampus 
throughout adulthood [23]. The neurotoxic effects of CPH include not only neuronal 
damage but also disruption of the cholinergic pathways [2]. The aforementioned 
reports point out that there is a necessity to explore the possible therapeutic 
approaches to mitigate the neurotoxicity induced by cyclophosphamide on 
hippocampal neurons. Therefore, the present study was conducted to investigate the 
potential ameliorative effect of the biologically synthesized nano Se on CPH induced 
hippocampal neurotoxicity. 
 
MATERIALS AND METHODS 
Drugs 
Cyclophosphamide (CPH) 
Cyclophosphamide monohydrate, trade name Endoxan, was manufactured by 
Baxter Oncology GmbH (Kantstrasse, Germany). It was available in the form of vials. 
Each vial contained 1 gm cyclophosphamide (dry powder). CPH was dissolved in 
saline to be intraperitoneally injected in rats. 
Selenium nano-particles (nano Se): 
Biologically synthesized nano Se was prepared using yoghurt culture 
(Lactobacillus delbrueckii subsp. bulgaricus (L. bulgaricus, NCAIM B 02206) and 
Streptococcus thermophilus (S. thermophiles, CNCM I-1670) cultivated in MRS 
medium as described by Prokisch and Zommara,2010 [41]. Nano Se size ranged from 
55-238 nm with an average of 122.6 ± 34.6 (SD) or 122.6 ± 8.6 (SE). Scanning 
electron microscopic (JSM-IT100, JEOL Co. Japan) photos of purified nano Se were 
used for nano Se size determination according to Nagy et al. 2016 (Fig.1) [35].  
Animals 
24 adult male albino rats with an average weight of 200-250 gm were used in 
the current experimental study. The animals were treated according to the guidelines 
of the CARE (Committee of Animal Research Ethics) of the faculty of medicine, Ain-
Shams University. The animals were housed in a convenient environment; six rats per 
cage, food, and water were freely allowed. All rats were exposed to 12 hours light-
dark cycle, good ventilation, and suitable temperature 22°-25° C.  
Experimental design 
Animals were divided into four groups: 
— Group I (control group): 6 rats received 0.1 ml of a saline intraperitoneal 
injection daily for 4 weeks. 
— Group II (Nano Se group):6 rats received nano Se (0.5 mg/kg body weight) by 
oral gavage daily for 4 weeks [16].   
— Group III (CPH group):6 rats received a CPH (20 mg/kg body weight) 
intraperitoneal injection daily for 4 weeks [34]. 
— Group IV (CPH plus nano Se group): 6 rats received a CPH (20 mg/kg body 
weight) intraperitoneal injection daily and nano Se (0.5 mg/kg body weight) 
by oral gavage daily for 4 weeks.  
 
Light microscopic studies 
At the end of the 4 weeks experimental period, rats were anesthetized by ether, 
and then sacrificed also with a fatal dose of ether. For each animal, the brain was 
extracted. The cerebral hemispheres were separated into right and left halves. Then, 
the posterior portion of the brain containing the hippocampus was cut. The right 
hippocampus was put in 10% formal saline (5 days). Specimens were then 
dehydrated, cleared, and embedded in paraffin. Sagittal sections (5-µm) were cut and 
stained with H&E [ 4], and immunohistochemical staining for caspase 3 (apoptotic 
marker) and GFAP (glial fibrillary acidic protein) were also performed. GFAP was 
utilized to investigate the astrocytes distribution and their response to neurocyte 
damage [31] 
Immunohistochemical staining  
Tissue sections were deparaffinized, rehydrated and 10% hydrogen peroxide 
was added for endogenous peroxidase inhibition. Then, boiling with citrate buffer pH 
6.0, For antigen retrieval was done. Sections were also incubated with the primary 
antibodies: anti-caspase 3 (BIOCYC GmbH, Germany), and anti-GFAP (Goat 
Polyclonal IgG, anti-rat antibody; Dako Cytomation, USA). Subsequently, incubation 
with the secondary antibody, a biotinylated goat anti-rabbit immunoglobulin and a 
streptavidin–biotin complex was done. The site of the reaction was visualized by 
adding diaminobenzidine HCl, which was converted into a brown precipitate by 
peroxidase. Finally, hematoxylin was utilized for counterstaining [5].  
 
Transmission electron microscopy 
The left hippocampal formation was extracted immediately after sacrificing 
the animals; samples were cut into small pieces (1×1×1 mm). The pieces were 
thereafter fixed in formal glutaraldehyde 2.5% for 2 days. Then, postfixation with a 
1% osmium tetroxide solution was performed. Washing four times with PBS and 
dehydration through graded ethanol was done followed by clearing in propylene. 
Finally, the specimens were embedded in epoxy resin. Semithin sections were cut (1 
µm) and stained with toluidine blue and inspected by light microscope. Then, cutting 
the ultrathin sections (60nm) and staining with uranyl acetate and lead citrate was 
done. The sections were examined using a transmission electron microscope (Jeol 
1200Ex, Japan) at the Electron Microscopy Center, Faculty of Science Ain Shams 
University, Cairo, Egypt.[42] 
Morphometric and statistical analysis  
The following data were measured:  
— The thickness of the neurocyte cell layer i.e. the pyramidal cell layer in CA1 
and CA3 zones and the granular cell layer in dentate (DG) gyrus. Vertical 
lines were drawn, by the software (Image Pro- Plus), from the uppermost 
pyramidal cell (or granule cell) to the lower most one detected. The lines were 
then measured. 
— The area percentage of GFAP reaction, and the number of GFAB positive 
cells in CA1 in all groups. Briefly, The GFAB positive cells were marked by 
the software and the area percentage and the number of cells were counted at 
the high-power field (×400 magnification).  
— The area percentage of caspase 3 reaction in CA1 in all groups. The caspase 3 
positive cells were marked by the software and the area percentage was 
counted at the high-power field (×400 magnification). The number of caspase 
3 positive cells (apoptotic cells) was expressed frequently in the previous 
studies by the apoptotic index (Ap index). [55] 
 
Five different captures in non-overlapping high-power fields (×400) were taken in 
the slides of each rat in all groups (the H&E stained slides and the immunostained 
slides). Then, the aforementioned parameters were measured by software. The Ap 
index represented the percentage of apoptotic cells in 1000 cells. Meanwhile, the Ap 
index was determined by counting at least 1000 cells per slide, subdivided into 10 
fields chosen randomly. The counting process was done at 400 × magnification. Ap 
index = (number of caspase 3 positive cells/total number of calculated cells) ×100. 
Measurements were performed by an independent observer blinded to the specimens’ 
details to achieve an unbiased evaluation. The morphometric analysis was performed 
on digital light microscopic images that had been captured by a digital camera 
Olympus (DP 20) on Olympus BX51 light microscope (Olympus, Hamburg, 
Germany). Image analysis procedures were carried out using the Image Pro-plus 
Program, Media cybernetics. Inc. (version 4.5.1.27).   
All data were expressed as mean ± SD and statistically analyzed by IBM SPSS 
Statistics version 20 using one-way AVOVA analysis of variance, followed by Tukey 
test to compare statistical differences between all groups at P < 0.05. 
 
RESULTS 
Light microscopic results 
Group (I&II) (Control and nano Se groups). The microscopic sections of 
the control and nano Se groups were nearly similar. In both groups, examination of 
H&E stained sections of the hippocampus revealed that it was formed of the 
hippocampal proper (proprius) and the dentate (DG) gyrus.  The hippocampus proper 
was composed of four zones (CA1, CA2, CA3, and CA4) of cornu ammonis. CA1 
and CA2 were located dorsally while CA3 made the descending arch that ended at the 
beginning of the hilus of the DG gyrus. CA4 is situated inside the hilus of the DG 
gyrus. The DG gyrus appeared as a dark V-shaped structure, with its open part 
encircling the CA4 area of the hippocampus.  Each area was formed of three layers: 
polymorphic, pyramidal, and molecular (Fig. 2A). The molecular and polymorphic 
layers contained few neurocytes (nerve cells), whereas the pyramidal layer was 
formed of numerous neurocytes (pyramidal cells) containing large vesicular nuclei 
with prominent nucleoli and pale basophilic cytoplasm. Glial cell interneurons were 
seen in all layers of the hippocampus. They had dark basophilic cytoplasm and deeply 
stained small rounded nuclei. The middle layer in the DG gyrus is called the granule 
cell layer instead of the pyramidal cell layer (Fig. 2B-D). The cellular structure of the 
various zones of the hippocampus proper is similar so figures of CA1 and CA3 were 
only included in the present study as examples to the different layers and to avoid 
repetition of unnecessary similar figures. 
Group (III) (CPH group). Hippocampus proper: The thickness of the 
pyramidal cell layer was apparently decreased. The pyramidal cells were disorganized 
and appeared either degenerated or necrotic. The cytoplasm of the degenerated cells 
was vacuolated with loss of cellular characteristics. The necrotic cells had shrunken 
deeply stained nuclei i.e. pyknotic nuclei. Small perineural spaces were seen 
surrounding the necrotic pyramidal cells. Additionally, some cells had swollen 
karyolitic pale stained nuclei with pale faint cytoplasm giving the ghost-like 
appearance. Few cells were still healthy with vesicular nuclei in between the damaged 
cells (Figs. 3A and B). 
DG gyrus: The granule cell layer was diminished in thickness and the majority of its 
cells had deeply stained shrunken pyknotic nuclei or ghost-like nuclei (Fig. 3C).   
Morphometrically, the thickness of the pyramidal cell layer and the granule cell layer 
(neurocyte cell layers) was significantly decreased as compared to the control group 
(p < 0.05). So, the morphometric data were in harmony with the morphological 
observations (table 1 & Fig. 4). 
Group (IV) (CPH plus Nano SE group). Examination of H&E-stained 
sections in the hippocampus of rats treated with CPH plus Nano Se revealed that most 
of the pyramidal cells and granule cells appeared healthy with large rounded or oval 
vesicular nuclei. Few cells with shrunken pyknotic nuclei with dark cytoplasm could 
be also seen in between the healthy cells (Fig. 3D, E, and F). The thickness of the 
pyramidal cell layer and the granule cell layer was significantly elevated as compared 
to CPH group by morphometric analysis (table 1& Fig. 4). 
 
Immunohistochemical results 
Immunohistochemistry for GFAP. The control group and the Nano Se group 
(I&II groups) showed few positive brownish star-shaped GFAP immunoreactive cells. 
The immunoreactive cells were large branched cells dispersed among various cell 
layers of the hippocampus.  They were most probably activated astrocytes (Fig. 5A). 
The CPH group (group III) showed an apparent increase in the number and size of the 
star-shaped GFAP immunoreactive cells (Fig. 5B). The CPH plus nano Se group 
(group IV) showed less number and size of the GFAP immunoreactive cells compared 
to the group of CPH treated Rats (Fig. 5C). Morphometrically, the area percentage of 
the GFAB reaction and the mean number of immunoreactive cells were significantly 
increased in the CPH group as compared to the control group. Meanwhile, these 
measured parameters were significantly reduced in CPH plus nano Se group as 
compared to the CPH group (Table 2 & Fig, 7A). 
Immunohistochemistry for Caspase 3. Caspase 3 was rarely expressed in the 
neurocytes of the control and Nano Se groups (group I&II) (Fig. 6A). Enhanced 
staining of caspase 3 was observed in the neurocytes of the CPH group (group III) 
compared with the control group, indicating increased apoptosis (Fig. 6B). The CPH 
plus Nano Se group (group IV) showed decreased staining in comparison with the 
CPH group (Fig. 6C). Morphometrically, the area percentage of caspase 3 reaction, 
and the apoptotic index were significantly increased in the CPH group compared to 
the control group. Meanwhile, these measured parameters were significantly 
decreased in CPH plus Nano Se group as compared to the CPH group. (Table 2 & Fig. 
7B). 
Transmission electron microscopic (TEM) results 
Group (I&II) (Control and nano Se groups). The Neurocytes (nerve cells) 
of the control group showed large oval or rounded euchromatic nucleus with 
dispersed chromatin and a regular nuclear membrane. The cytoplasm contained 
multiple cisternae of rough endoplasmic reticulum (Er), several free ribosomes, and 
intact mitochondria with prominent cristae (Fig. 8). 
Group (III) (CPH group). The nuclei of many cells had irregular outlines 
and condensed chromatin and some of them appeared shrunken and deeply stained i.e. 
pyknotic (Fig. 9 A and C). The nuclei of the degenerated cells appeared electro-lucent 
but their cytoplasm showed large vacuolation with remnants of the degenerated 
organelles (Fig. 9 B). The mitochondrial cristae appeared damaged i.e. cristeolysis 
and the cisternae the rough Er were slightly dilated (Fig 9 D). Some neurolemmal 
sheaths of the nerve fibers were disrupted (Fig. 9A and C). 
Group (IV) (CPH plus Nano SE group). The majority of cells had electro-
lucent nuclei with nearly regular outlines and dispersed chromatin and their cytoplasm 
showed healthy mitochondria and a nearly normal rough Er. The neurolemmal sheaths 
of the nerve fibers appeared intact (Fig. 10 A and B). Some cells had normal 
cytoplasmic organelles and electro-lucent chromatin, but their nuclei still had 
irregular outlines (Fig. 10 C).  While most of the cells appeared healthy, few cells still 
had deeply stained nuclei and/or cytoplasmic vacuolation (Fig. 10 D). 
 
DISCUSSION 
Chemotherapeutic drugs as cyclophosphamide have been a cornerstone of 
cancer therapy. Extensive effort was done on the synthesis of more efficient and less 
toxic chemotherapeutic drugs, but less attention has been paid to factors that may 
decrease the harmful side effects created by the antineoplastic agents. Moreover, the 
clinical outcome of treatment with these agents is critically restricted, frequently due 
to their toxicity to normal tissues. Consequently, there was a need to develop adjuvant 
treatment to enhance the effectiveness and/or diminish the associated side effects. 
Nanoparticles have the potential to overcome the obstacles in the treatment of cancer 
by the traditional antineoplastic agents, due to the unique nano size and novel 
characteristics of nanomaterials [27,59]. 
In the current study, H&E stained sections of the group of rats exposed to 
CPH showed either degeneration or necrosis of the neurocytes of the hippocampus i.e. 
the pyramidal cells of the hippocampus proper and granule cells of the dentate gyrus. 
The thickness of the pyramidal and granule cell layers was also significantly reduced. 
The results of the current study were similar to the observations of Shaibah et.al.,2016 
who postulated that CPH caused highly significant dystrophic and apoptotic 
alterations in the neurocytes of the hippocampus with a marked reduction in the 
neurocyte cell layer thickness [44]. On the contrary, Lyons et.al.,2011 pointed out that 
CPH did not affect the survival of the cells of the hippocampus in rats after a short-
term treatment and it is less neurotoxic than other antineoplastic agents. [30] 
Consequently, it is concluded that CPH could provoke neuronal damage in the 
hippocampus due to the long term and not in short term treatment. 
The H&E stained sections of the rats treated with CPH plus nano SE, in the 
present study, showed that most of the neurocytes were healthy in the hippocampus 
apart from few cells exhibited dystrophic changes. Additionally, the thickness of the 
pyramidal cell layer and granule cell layer was significantly increased as compared to 
the CPH group. These ameliorating results induced by nano Se were in harmony with 
the previous studies insuring the ameliorating effect of nano Se on the different 
tissues against the tissue deleterious effect of cyclophosphamide and the other 
injurious factors. In this context, Bhattacharjee et. Al.,2014 reported that nano Se 
alleviated degenerative changes in the liver induced by CPH. [7] Moreover, Hamza et. 
al.,2020 reported that nano Se could protect also against the hepatocellular damage 
induced by acrylamide [17]. Additionally, Dkhil et.al.,2016 stated that nano Se 
prevented and minimized diabetes-induced spermatogenic cell loss in diabetic rats. 
[13].  Similarly, Abdel Hakeem EA et. al.,2020 reported that nano Se could mitigate 
the degeneration, necrosis, and inflammation of pancreatic acini and Langerhans cells 
caused by acute pancreatitis [1]. 
The protective effect of nano Se on the hippocampus and the other tissues may 
be due to its antioxidant power against the oxidant damaging effect of CPH as stated 
by the previous studies. Akomolafe et. Al., 2020 Postulated that CPH has a pro-
oxidant character and its administration is associated with induction of oxidative 
stress by the generation of free radicals [2]. Moreover, Valko et. al.,2006 reported that 
higher levels of malondialdehyde (MDA) were noted in the brain of CPH treated 
mice. MDA is an outcome of lipid peroxidation and has been recorded to cause 
neuronal damage [52]. On the other hand, nano Se significantly inhibited CPH 
induced free radicals formation which may be due to its antioxidant property [7]. 
Nano Se played important roles in the enhancement of the antioxidant defense system 
and scavenging free radicals by increasing activities of both and glutathione S-
transferase and Glutathione peroxidase [20,40,58] 
In the present study, the thickness of the neurocyte cell layers (pyramidal and 
granule layers) was significantly reduced in the group treated with CPH. This 
reduction occurred due to the decrease in the neurocyte population owing to the 
cellular damage (necrosis and/or apoptosis). Additionally, the reduction in the 
population of cells may be also due to the inhibition of hippocampal neurogenesis by 
CPH that was mentioned recently in numerous studies. The reduction in hippocampal 
neurogenesis by CPH could affect the hippocampal related cognitive functions and 
memory [12,56]. Nano Se, in the present study, prevented the decrease in the 
thickness of neurocyte cell layers in the group treated with CPH plus nano Se. This 
may be due to the prevention of cellular degeneration, necrosis, and apoptosis by nano 
Se. The positive impact of nano Se on neurogenesis may be also assumed which could 
be an additional cause of increased neurocyte cell layers thickness. 
Caspase-3 has been known as an essential therapeutic target in 
neurodegeneration owing to its involvement in neuroinflammation and apoptosis [21]. 
Immunohistochemical examination and morphometric analysis, in the current study, 
revealed that CPH injection significantly increased the area percentage of caspase 3 
reaction and the apoptotic index which reflected the increase in the number of cells 
showing positive reactions to caspase 3 (an apoptosis marker). This result was in line 
with the observations of Shaibah et.al.,2016 who reported that immunohistochemical 
section of rats injected with CPH showed a large number of apoptotic neurons with a 
positive reaction for p53 (an apoptosis marker) and a less positive reaction for Bcl2 
(anti-apoptotic marker) [44]. 
The immunohistochemical results also revealed that nano Se reduced the area 
percentage of caspase 3 reaction and the apoptotic index in the group exposed to CPH 
plus nano Se. Our results were in harmony with that of Wang et.al.,2019 who studied 
the effect of nano Se on cultured pancreatic cells. They stated that nano Se completely 
inhibited the activation of caspase-3, 8, and 9 and consequently, suppressing apoptosis 
[53]. On the contrary Huang et. al., 2010 proved that nano-Se provoked initiation of 
apoptosis through destabilization of the membrane potential of mitochondria and 
raised the expression of many pro-apoptotic caspases [18]. These differences in 
results may due to the variations in doses and sizes of nano Se utilized. As for nano Se 
to produce apoptosis, it should reside within the cell at high concentrations. 
Moreover, the diversity in cell type upon which nano Se acts, the variations in cellular 
redox status, and different durations of administration may be other causes [22] 
GFAP is a cellular protein that is found in various cell types of the brain 
particularly astrocytes [48]. GFAP is known to be essential for changing astrocyte 
shape and mobility by increasing the structural stability of the processes of astrocytes 
[29]. GFAP is also known as a specific marker for the maturity of astrocytes [14]. It 
was found that injury of the brain, whether because of chemical agents, diseases, or 
trauma led to astrogliosis. In astrogliosis, rapid synthesis of GFAP occurs and is 
detected by immunostaining with GFAP antibodies [26]. In the current study, CPH 
triggered the activation of astrocytes that was manifested in the form of increased 
expression of GFAP. This might be a compensatory mechanism for neuronal damage. 
Moreover, nano Se significantly reduced the expression of GFAB which indicated 
that nano Se could inhibit CPH induced neuronal damage and its concomitant 
astrogliosis.   
So far, there was very limited data in the previous studies about the effect 
CPH on the ultrastructure of the hippocampus in adult rats. By TEM, the results of the 
present study revealed that CPH produced mild dilation of rough ER., mitochondrial 
cristeolysis, disrupted neurolemmal sheaths of nerve fibers, neuronal degeneration, 
and necrosis which was greatly reversed by nano Se co-treatment. Our observations 
were in harmony with the developmental study of Xiao et.al.,2007 who reported that 
CPH decreased the growth and viability of neurons, destroyed nuclear DNA, and 
provoked apoptotic morphological alterations in rat embryos. [ 54]. CPH may induce 
neuroinflammation and neurodegeneration due to enhancing NO synthesis and 
increasing arginase activity. Experimental studies have revealed that elevated arginase 
activity and changes in NO levels may contribute to neurodegeneration [11,38]. 
Additionally, Mohammed and Safwat, 2013 reported that the administration of nano 
Se significantly decreased the NO concentration in brain tissue [33]. So, the reduction 




Cyclophosphamide injection in rats triggered cellular degeneration, necrosis, 
and apoptosis of hippocampal neurocytes. Moreover, it caused mild dilation of rough 
endoplasmic reticulum, mitochondrial cristeolysis, and disrupted neurolemmal 
sheaths of nerve fibers at the ultrastructural level. Nano selenium co-treatment 
mitigated these deleterious changes induced by cyclophosphamide. So, nano selenium 
Supplementation to the diet of patients treated with cyclophosphamide may be useful. 
Further studies are required to elucidate the mechanism of action nano selenium as a 
protective factor against chemotherapeutic drugs as cyclophosphamide. 
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Table 1. Thickness of the pyramidal cell layer in CA1 and CA3 and the granular cell 
layer in dentate gyrus of the hippocampus in different groups (in µM) 
 Control Nano Se CPH CPH+ Nano Se 
CA1 84.28±7.41 87.48±7.75 a4.11±40.26 b 7.18±76.94 
CA3 112.34±5.50 116.56±6.27 a 5.46±57.97 b 8.00±107.06 
Dentate gyrus 69.61±4.67 71.92±4.06 a 3.70±40.31 b  6.95±63.91 
Values are expressed as mean ± standard deviation. N=6 for each group. One-way 
ANOVA. a= significant versus the control group; b= significant versus the CPH 




Table 2. The mean GFAP area %, number of GFAB positive cells, caspase 3 area %, 












Control 2.99±1.57 2.73±1.44 .850±1.44 0.25±0.43 
Nano Se 2.24±1.53 1.73±1.23 1.24±0.92 0.32±0.15 
CPH a10.25±18.56 a6.60±19.23 a6.12±15.06 a  5.14±33.66 
CPH+ Nano Se b 2.96±7.07 b2.11±5.47 b1.61±5.73 b 2.58±10.54 
Values are expressed as mean ± standard deviation. N=6 for each group. One-way ANOVA. a= 








Figure 2. A) hippocampus of control rat showing the DG gyrus and the four regions 
of hippocampus CA1,CA2,CA3, and CA4.B,C, and D) showing that CA1,CA3 and 
DG gyrus are formed of 3 layers: PL=polymorphic layer, p=pyramidal cell layer , and 
M=molecular cell layer. The pyramidal cell layer is replaced by granule cell layer (G) 
in DG gyrus. The thick arrows point to the pyramidal and granule cells and the thin 





Figure 3. A,B, and C) Sections from CPH group showing the necrotic and 
degenerated neurocytes in all zones separated by few healthy cells. D,E, and F) 
sections in CPH plus Nano SE group showing that most of the neurocytes are healthy. 
Thick arrow= necrotic cell, thin arrow= healthy cell, yellow arrow= ghost like cell, 




Figure 4. A histogram comparing the neurocyte cell layer thickness of the different 
groups. 
 
Figure 5. Sections in CA1 A) Few cells with positive reaction to GFAB in the control 
group. B) Many cells with positive reaction in CPH group. C) Few cells with positive 
reaction in CPH plus Nano Se group.   (GFAB immune- stain X 400) 
 
 
Figure 6. Sections in CA1 A) No positive reaction to caspase 3 in the control group. 
B) Many cells with positive reaction in CPH group. C) Few cells with positive 




Figure 7. A histogram comparing; A) GFAP area percentage and number of GFAP 
positive cells in the different groups, B) Caspase 3 area percentage and apoptotic 






Figure 8. TEM micrograph of a control neurocyte showing a large oval euchromatic 
nucleus (N), cisternae of rough Er (thin arrow), and intact mitochondria (thick arrow)        






Figure 9. TEM micrographs of neurocytes of the CPH group A)  showing a nucleus 
(N) with  irregular outline and condensed chromatin. B) showing a degenerated cell 
with electro lucent nucleus (N), vacuolated cytoplasm (V), and remnants of the 
degenerated organelles (R). C) showing a necrotic cell with a pyknotic nucleus (N). 
D) a higher magnification of C showing the cristeolysis of mitochondria (thick arrow) 
and the slightly dilated cisternae the rough Er (blue arrow). N.B.: The disrupted 
neurolemmal sheaths (thin arrow) are seen in A and C. (A&C  X2500, B X1500,  D 





Figure 10. TEM micrographs of neurocytes of the CPH plus nano Se group A) 
showing a cell with electro-lucent nucleus (N) with a nearly regular outline and 
dispersed chromatin. B) a higher magnification of A showing healthy mitochondria 
(thick arrow), nearly normal rough E (blue arrow), and intact neurolemmal sheaths 
(thin arrow). C) showing a cell with electro-lucent nucleus(N) with irregular outline. 
D) showing healthy cells (H) and damaged cells (D) with deeply stained nuclei and 
cytoplasmic vacuolation (V).  (A&C X2500, B X6000,  D X1500) 
 
 
